Targeted Cell-to-Cell Delivery of Protein Payloads via the Granzyme-Perforin Pathway

[1]  R. Holt,et al.  Cell-Based Therapeutics: Making a Faustian Pact with Biology. , 2017, Trends in molecular medicine.

[2]  S. Janes,et al.  Genetically modified mesenchymal stromal cells in cancer therapy , 2016, Cytotherapy.

[3]  Kole T. Roybal,et al.  Precision Tumor Recognition by T Cells With Combinatorial Antigen-Sensing Circuits , 2016, Cell.

[4]  Russell M. Gordley,et al.  Engineering Customized Cell Sensing and Response Behaviors Using Synthetic Notch Receptors , 2016, Cell.

[5]  E. van Meel,et al.  Multiple Domains of GlcNAc-1-phosphotransferase Mediate Recognition of Lysosomal Enzymes* , 2016, The Journal of Biological Chemistry.

[6]  J. Mecsas,et al.  Bacterial Secretion Systems: An Overview , 2016, Microbiology spectrum.

[7]  D. Mcfadden,et al.  Thioredoxin-1 (Trx1) engineered mesenchymal stem cell therapy increased pro-angiogenic factors, reduced fibrosis and improved heart function in the infarcted rat myocardium. , 2015, International journal of cardiology.

[8]  Fabio Catani,et al.  Mesenchymal stem/stromal cells as a delivery platform in cell and gene therapies , 2015, BMC Medicine.

[9]  D. Coombs,et al.  Design Parameters for Granzyme-Mediated Cytotoxic Lymphocyte Target-Cell Killing and Specificity. , 2015, Biophysical journal.

[10]  James C. Whisstock,et al.  Perforin and granzymes: function, dysfunction and human pathology , 2015, Nature Reviews Immunology.

[11]  Gabriel Waksman,et al.  Secretion systems in Gram-negative bacteria: structural and mechanistic insights , 2015, Nature Reviews Microbiology.

[12]  A. Wagers,et al.  Engineering Escherichia coli into a Protein Delivery System for Mammalian Cells , 2015, ACS synthetic biology.

[13]  Seth M Steinberg,et al.  T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial , 2015, The Lancet.

[14]  Ying Ge,et al.  Cardiac repair in a porcine model of acute myocardial infarction with human induced pluripotent stem cell-derived cardiovascular cells. , 2014, Cell stem cell.

[15]  D. Davis,et al.  The immune synapse clears and excludes molecules above a size threshold , 2014, Nature Communications.

[16]  Pamela A Shaw,et al.  Chimeric antigen receptor T cells for sustained remissions in leukemia. , 2014, The New England journal of medicine.

[17]  Ron Weiss,et al.  Systematic Transfer of Prokaryotic Sensors and Circuits to Mammalian Cells , 2014, ACS synthetic biology.

[18]  D. Davies,et al.  Systemic but not topical TRAIL-expressing mesenchymal stem cells reduce tumour growth in malignant mesothelioma , 2014, Thorax.

[19]  Vikas Nanda,et al.  Potential Pitfalls and Solutions for Use of Fluorescent Fusion Proteins to Study the Lysosome , 2014, PloS one.

[20]  Qing He,et al.  Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia , 2014, Science Translational Medicine.

[21]  S. Rosenberg,et al.  Exploiting the curative potential of adoptive T‐cell therapy for cancer , 2014, Immunological reviews.

[22]  D. Mcfadden,et al.  Thioredoxin-1 (Trx-1) engineered mesenchymal stem cell therapy increased proangiogenic factors, reduced fibrosis and improved heart function in the infarcted rat myocardium , 2013 .

[23]  J. Trapani,et al.  Rapid and Unidirectional Perforin Pore Delivery at the Cytotoxic Immune Synapse , 2013, The Journal of Immunology.

[24]  Helen R Saibil,et al.  Perforin forms transient pores on the target cell plasma membrane to facilitate rapid access of granzymes during killer cell attack. , 2013, Blood.

[25]  Wendell A. Lim,et al.  Cell-Based Therapeutics: The Next Pillar of Medicine , 2013, Science Translational Medicine.

[26]  Michel Sadelain,et al.  The basic principles of chimeric antigen receptor design. , 2013, Cancer discovery.

[27]  R. Vale,et al.  Biophysical Mechanism of T Cell Receptor Triggering in a Reconstituted System , 2012, Nature.

[28]  F. Schwab,et al.  Selective Targeting of Genetically Engineered Mesenchymal Stem Cells to Tumor Stroma Microenvironments Using Tissue-Specific Suicide Gene Expression Suppresses Growth of Hepatocellular Carcinoma , 2011, Annals of surgery.

[29]  J. Lieberman,et al.  Perforin pores in the endosomal membrane trigger release of endocytosed granzyme B to the cytosol of target cells , 2011, Nature Immunology.

[30]  J. Whisstock,et al.  The structural basis for membrane binding and pore formation by lymphocyte perforin , 2010, Nature.

[31]  Steven J. M. Jones,et al.  A regulatory toolbox of MiniPromoters to drive selective expression in the brain , 2010, Proceedings of the National Academy of Sciences.

[32]  A. Fischer,et al.  Molecular mechanisms of biogenesis and exocytosis of cytotoxic granules , 2010, Nature Reviews Immunology.

[33]  Wendell A. Lim,et al.  Designing customized cell signalling circuits , 2010, Nature Reviews Molecular Cell Biology.

[34]  Martin Fussenegger,et al.  Self-sufficient control of urate homeostasis in mice by a synthetic circuit , 2010, Nature Biotechnology.

[35]  S. Kornfeld,et al.  Functions of the α, β, and γ Subunits of UDP-GlcNAc:Lysosomal Enzyme N-Acetylglucosamine-1-phosphotransferase* , 2009, The Journal of Biological Chemistry.

[36]  P. Saftig,et al.  Lysosome biogenesis and lysosomal membrane proteins: trafficking meets function , 2009, Nature Reviews Molecular Cell Biology.

[37]  J. Bonifacino,et al.  Sorting of lysosomal proteins. , 2009, Biochimica et biophysica acta.

[38]  L. Ou,et al.  Targeted migration of mesenchymal stem cells modified with CXCR4 gene to infarcted myocardium improves cardiac performance. , 2008, Molecular therapy : the journal of the American Society of Gene Therapy.

[39]  Christopher A. Voigt,et al.  Environmental signal integration by a modular AND gate , 2007, Molecular systems biology.

[40]  S. Fuller,et al.  Centrosome polarization delivers secretory granules to the immunological synapse , 2006, Nature.

[41]  Christopher A. Voigt,et al.  Environmentally controlled invasion of cancer cells by engineered bacteria. , 2006, Journal of molecular biology.

[42]  R. Rudolph,et al.  Killing of target cells by redirected granzyme B in the absence of perforin , 2004, FEBS letters.

[43]  Craig J. Thalhauser,et al.  Role of N-Linked Oligosaccharide Flexibility in Mannose Phosphorylation of Lysosomal Enzyme Cathepsin L* , 2002, The Journal of Biological Chemistry.

[44]  R. Bleackley,et al.  Cytotoxic T lymphocytes: all roads lead to death , 2002, Nature Reviews Immunology.

[45]  Søren Brunak,et al.  Prediction of Glycosylation Across the Human Proteome and the Correlation to Protein Function , 2001, Pacific Symposium on Biocomputing.

[46]  M. Aebi,et al.  N-linked protein glycosylation in the endoplasmic reticulum. , 2000, Cold Spring Harbor perspectives in biology.

[47]  Robert Fletterick,et al.  The structure of the pro-apoptotic protease granzyme B reveals the molecular determinants of its specificity , 2000, Nature Structural Biology.

[48]  R. Demars,et al.  Production of human cells expressing individual transferred HLA-A,-B,-C genes using an HLA-A,-B,-C null human cell line. , 1989, Journal of immunology.

[49]  Susheel Kumar,et al.  Therapeutic potential of genetically modified mesenchymal stem cells , 2008, Gene Therapy.

[50]  S. Fuller,et al.  Centrosome polarization delivers secretory granules to the immunological synapse , 2006, Nature.

[51]  M. Blázquez,et al.  Basic mechanisms of secretion: sorting into the regulated secretory pathway. , 2000, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[52]  Z. Brahmi,et al.  Upregulation of B7 molecules by the Epstein-Barr virus enhances susceptibility to lysis by a human NK-like cell line. , 1995, Cellular immunology.